Showing results (51-60 of 384) with videos related to
Sort By:
Pageof 39
Biochemistry|October 14, 1980
(p-Amidinophenyl)methanesulfonyl fluoride, an irreversible inhibitor of serine proteasesR Laura, D J Robison, D H BingThe Journal of Biological Chemistry|January 25, 1983
The binding properties of human complement component C1q. Interaction with mucopolysaccharidesS Almeda, R D Rosenberg, D H BingThe Journal of Antimicrobial Chemotherapy|June 1, 1992
In-vitro activity of tosufloxacin, a new quinolone antibacterial agentM A Cooper, J M Andrews, R WiseThe Journal of General Virology|January 8, 1999
The effect of the cellular stress response on human T-lymphotropic virus type I envelope protein expressionJ M Andrews, M Oglesbee, M D LairmoreThe Journal of Antimicrobial Chemotherapy|May 1, 1992
In-vitro activity of PD 131628, a new quinolone antimicrobial agentM A Cooper, J M Andrews, R WiseAntimicrobial Agents and Chemotherapy|March 1, 1978
In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillinR Wise, J M Andrews, K A BedfordThe Journal of Antimicrobial Chemotherapy|October 3, 2001
Activity of daptomycin against Gram-positive pathogens: a comparison with other agents and the determination of a tentative breakpointR Wise, J M Andrews, J P AshbyThe Journal of Antimicrobial Chemotherapy|June 1, 1997
Postantibiotic effect of trovafloxacin on Pseudomonas aeruginosaF J Boswell, J M Andrews, R WiseThe Journal of Antimicrobial Chemotherapy|June 25, 1999
Study to assess the reliability of a disc diffusion method for determining the sensitivity of gram-positive pathogens to dalfopristin/quinupristinJ M Andrews, J P Ashby, R WiseThe Journal of Antimicrobial Chemotherapy|November 1, 1990
In-vitro activity of cefodizime against respiratory pathogensR Wise, J M Andrews, J P AshbyPageof 39